查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1777252

肽化妆品用API的全球市场:供给来源·用途·终端用户产业·各地区 (～2035年)

Global Peptide Cosmetic API Research Report by Source, by Application, by End-Use Industry, by Region Market Forecast till 2035
出版日期: | 出版商: Market Research Future | 英文 169 Pages | 订单完成后即时交付

价格

全球肽化妆品原料药 (API) 市场预计将从 2024 年的 9.213 亿美元成长至 2035 年的 29.684 亿美元，复合年增长率为 11.2%。

全球肽化妆品原料药 (API) 市场正经历强劲成长，这主要得益于消费者对天然和有机美容解决方案日益增长的需求。人们对皮肤安全和永续性的认识不断提高，促使人们关注符合清洁美容标准的肽产品。肽合成技术的快速进步使得能够创造出更稳定、更有效的化妆品配方。此外，针对特定皮肤问题的个人化护肤需求日益增长，也推动了可客製化肽类产品的使用。皮肤病学研究的进展为肽类护肤品的有效性提供了越来越多的科学证据，进一步加速了市场应用。

然而，市场仍面临诸多障碍。高昂的合成和配方成本、产品稳定性和递送机制方面的课题，以及可能延迟产品核准的复杂监管流程，都是限制因素。来自替代活性成分的竞争也是一个限制因素。

儘管面临这些课题，但成长前景依然强劲，尤其是在生物工程肽、人工智慧护肤品、男士专用抗衰老产品、多步骤护肤程序以及肽研究创新等领域。

区域分析

北美引领全球肽化妆品原料药市场。这得益于市场对肽化妆品原料药功能性和抗衰老功效的浓厚兴趣、消费者的广泛认可以及成熟护肤品牌的涌现。此外，先进的研究基础和对基于科学的高端产品的偏好也推动着市场的成长。

欧洲也是一个重要的市场。对纯净美容的需求、严格的成分监管以及德国、法国和英国蓬勃发展的抗衰老市场，正在支撑市场的成长。

在亚太地区，韩妆和日妆的影响力、快速的城市化进程以及偏爱多功能护肤品的年轻群体，正在推动中国、日本、韩国等国的市场快速增长。

本报告探讨了全球肽类化妆品原料药市场，并提供了市场定义和概述、影响市场成长的各种因素分析、市场规模趋势和预测、按细分市场、地区和主要国家/地区进行的细分、竞争格局以及主要公司的概况。

目录

第1章 摘要整理

第2章 市场概要

第3章 调查手法

第4章 市场动态

  • 促进因素
    • 对天然和有机化妆品的需求不断增长
    • 肽合成技术的进步
    • 对个人化护肤解决方案的兴趣日益浓厚
    • 肽在皮肤科功效方面的研究不断扩展
  • 限制因素
    • 肽合成和配方成本高昂
    • 稳定性与递送课题
    • 监理复杂性和审批延迟
    • 来自替代活性成分的竞争
  • 机遇
    • 清洁美容中的生物工程肽
    • 人工智慧驱动的个人化护肤
    • 多步骤护肤中的肽
    • 男士美容和抗衰老解决方案
    • 肽研究的创新
  • COVID-19影响分析

第5章 市场要素分析

  • 供应链分析
  • 波特的五力分析

第6章 肽化妆品用API市场:各用途

  • 抗老化和减少皱纹
  • 皮肤修復与再生
  • 保湿和补水
  • 美白和亮泽
  • 头髮护理
  • 抗发炎舒缓

第7章 肽化妆品用API市场:不同供应商

  • 植物来源肽
  • 动物原来肽
  • 生物工程肽
  • 化学合成

第8章 肽化妆品用API市场:各终端用户产业

  • 护肤
  • 护髮
  • 注射型化妆品
  • 其他

第9章 肽化妆品用API市场:各地区

  • 概要
  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 俄罗斯
    • 义大利
    • 西班牙
    • 其他
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 马来西亚
    • 泰国
    • 印尼
    • 其他
  • 南美
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他
  • MEA
    • GCC各国
    • 南非
    • 其他

第10章 竞争情形

  • 市场占有率分析
  • 竞争仪表板

第11章 企业简介

  • DSM-FIRMENICH
  • BACHEM
  • LIPOTRUE SCIENCE
  • CRODA
  • CAREGEN
  • BASF SE
  • EVONIK INDUSTRIES AG
  • GIVAUDAN ACTIVE BEAUTY
  • ASHLAND GLOBAL HOLDINGS
  • SYMRISE AG
  • PROVITAL GROUP
  • SPEC-CHEM INDUSTRY INC
  • AMBIOPHARM
  • LIPOTEC
  • USV PRIVATE LIMITED
  • CHEMISCHES LABORATORIUM DR. KURT RICHTER GMBH(CLR)
  • ACTIVE PEPTIDE COMPANY
  • SEIWA KASEI CO., LTD
  • RS SYNTHESIS
  • BCN PEPTIDES
Product Code: MRFR/HC/38117-HCR

Global Peptide Cosmetic API Research Report by Source (Plant-Derived Peptides, Animal-Derived Peptides, Bioengineered Peptides, Chemically Synthesized), by Application (Anti-Aging & Wrinkle Reduction, Skin Repair & Regeneration, Moisturizing & Hydration, Whitening & Brightening, Hair Care, Anti-Inflammatory & Soothing), by End-Use Industry (Skincare, Haircare, Injectable Cosmetics, Others), by Region (North America, Europe, APAC, South America, MEA) Market Forecast till 2035

Industry Overview

The global peptide cosmetic API market is expected to achieve from its 2024 estimate of USD 921.3 million to USD 2,968.4 million by 2035 at a compound annual growth rate (CAGR) of 11.2%.

Global peptide cosmetic API market is witnessing robust growth, largely fueled by increasing consumer demand for natural and organic beauty solutions. As people become more conscious of skin safety and sustainability, they are turning to peptide-based products that align with clean beauty standards. Rapid technological progress in peptide synthesis has enabled the creation of more stable and effective cosmetic formulations. Moreover, the rising inclination toward personalized skincare regimens has boosted the use of peptides, which can be customized for targeted skin concerns. Expanding dermatological research continues to validate the efficacy of peptides in skincare, further promoting their market adoption.

Nevertheless, the market does encounter several barriers. These include the high cost of synthesis and formulation, challenges in product stability and delivery mechanisms, and complex regulatory processes that can delay product approvals. Competition from alternative active ingredients also poses limitations.

Despite these challenges, growth prospects remain strong, especially in areas like bioengineered peptides, AI-driven skincare, male-focused anti-aging products, multi-step skincare routines, and peptide research innovations.

Industry Segmentations

Based on the application category, the global market is included anti-aging & wrinkle reduction, skin repair & regeneration, moisturizing & hydration, whitening & brightening, hair care, anti-inflammatory & soothing.

Chemically synthesized, plant-derived, animal-derived, and bioengineered peptides are all included in the global peptide cosmetic API market, which is divided by source type.

In terms of end-use variation, the global market is segmented into Skincare, haircare, injectable cosmetics, and others.

Regional Analysis

The global peptide cosmetic API market sees North America leading, thanks to widespread awareness, established skincare brands, and strong interest in functional, anti-aging solutions. Advanced research infrastructure and preference for premium, science-led products are key growth enablers.

Europe is a significant player as well, shaped by clean beauty demand, robust ingredient regulations, and a thriving anti-aging sector in Germany, France, and the UK.

Asia-Pacific is experiencing rapid growth, influenced by K-beauty and J-beauty, surging urbanization, and a young population inclined toward multifunctional skincare in China, Japan, and South Korea.

Latin America is gaining traction, primarily due to Brazil's expanding market for natural and anti-aging cosmetics.

Meanwhile, growth in the Middle East & Africa remains moderate but promising, supported by increasing disposable income and urban expansion.

Key Players

Key competitors of global peptide cosmetic API research report are Chemisches Laboratorium Dr. Kurt Richter GmbH, DSM-Firmenich, Provital Group, Bachem, Lipotrue Science, Croda, Caregen, BASF SE, Evonik Industries AG, Givaudan Active Beauty, Ashland Global Holdings, Symrise AG, Spec-Chem Industry Inc, Ambiopharm, Lipotec, USV Private Limited, Active Peptide Company, Seiwa Kasei Co. Ltd., RS Synthesis, BCN Peptides.

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

  • 2.1 DEFINITION
  • 2.2 SCOPE OF THE STUDY
  • 2.3 RESEARCH OBJECTIVE
  • 2.4 MARKET STRUCTURE

3 RESEARCH METHODOLOGY

  • 3.1 OVERVIEW
  • 3.2 DATA FLOW
    • 3.2.1 DATA MINING PROCESS
  • 3.3 PURCHASED DATABASE:
  • 3.4 SECONDARY SOURCES:
    • 3.4.1 SECONDARY RESEARCH DATA FLOW:
  • 3.5 PRIMARY RESEARCH:
    • 3.5.1 PRIMARY RESEARCH DATA FLOW:
    • 3.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED
    • 3.5.3 PRIMARY RESEARCH: REGIONAL COVERAGE
  • 3.6 APPROACHES FOR MARKET END USER ESTIMATION:
    • 3.6.1 REVENUE ANALYSIS APPROACH
    • 3.6.2 DATA FORECASTING
    • 3.6.3 DATA FORECASTING TECHNIQUE
  • 3.7 DATA MODELING
    • 3.7.1 MICROECONOMIC FACTOR ANALYSIS:
    • 3.7.2 DATA MODELING:
  • 3.8 TEAMS AND ANALYST CONTRIBUTION

4 MARKET DYNAMICS

  • 4.1 INTRODUCTION
  • 4.2 DRIVERS
    • 4.2.1 INCREASING DEMAND FOR NATURAL AND ORGANIC COSMETICS
    • 4.2.2 TECHNOLOGICAL ADVANCEMENTS IN PEPTIDE SYNTHESIS
    • 4.2.3 GROWING PREFERENCE FOR PERSONALIZED SKINCARE SOLUTIONS
    • 4.2.4 EXPANDING RESEARCH ON PEPTIDE BENEFITS IN DERMATOLOGY
  • 4.3 RESTRAINTS
    • 4.3.1 HIGH COST OF PEPTIDE SYNTHESIS AND FORMULATION
    • 4.3.2 STABILITY AND DELIVERY CHALLENGES
    • 4.3.3 REGULATORY COMPLEXITIES AND APPROVAL DELAYS
    • 4.3.4 COMPETITION FROM ALTERNATIVE ACTIVE INGREDIENTS
  • 4.4 OPPORTUNITY
    • 4.4.1 BIOENGINEERED PEPTIDES IN CLEAN BEAUTY
    • 4.4.2 AI-DRIVEN PERSONALIZED SKINCARE
    • 4.4.3 PEPTIDES IN MULTI-STEP SKINCARE REGIMENS
    • 4.4.4 MEN'S GROOMING AND ANTI-AGING SOLUTIONS
    • 4.4.5 INNOVATIONS IN PEPTIDE RESEARCH
  • 4.5 IMPACT ANALYSIS OF COVID - 19
    • 4.5.1 IMPACT 0N OVERALL HEALTHCARE.
    • 4.5.2 ECONOMIC IMPACT.
    • 4.5.3 IMPACT ON GLOBAL PEPTIDE COSMETIC API MARKET MARKET.
    • 4.5.4 IMPACT ON SUPPLY CHAIN OF PEPTIDE COSMETIC API MARKET
    • 4.5.5 PRICE VARIATION OF KEY RAW MATERIALS.
    • 4.5.6 PRODUCTION SHUTDOWN.
    • 4.5.7 CASH FLOW CONSTRAINTS.
    • 4.5.8 IMPACT ON IMPORT/EXPORT.
    • 4.5.9 IMPACT ON MARKET DEMAND OF PEPTIDE COSMETIC API MARKET.
    • 4.5.10 IMPACT DUE TO RESTRICTIONS/LOCKDOWN.
    • 4.5.11 CONSUMER SENTIMENTS.
    • 4.5.12 IMPACT ON PRICING OF PEPTIDE COSMETIC API MARKET.

5 MARKET FACTOR ANALYSIS

  • 5.1 SUPPLY CHAIN ANALYSIS
    • 5.1.1 RAW MATERIAL PROCUREMENT
    • 5.1.2 MANUFACTURING & SYNTHESIS
    • 5.1.3 PACKAGING AND STORAGE
    • 5.1.4 DISTRIBUTION & LOGISTICS
    • 5.1.5 END-USERS & CONSUMER DELIVERY
  • 5.2 PORTER'S FIVE FORCES MODEL
    • 5.2.1 BARGAINING POWER OF SUPPLIERS
    • 5.2.2 BARGAINING POWER OF BUYERS
    • 5.2.3 THREAT OF NEW ENTRANTS
    • 5.2.4 THREAT OF SUBSTITUTES
    • 5.2.5 INTENSITY OF RIVALRY

6 PEPTIDE COSMETIC API MARKET, BY APPLICATION

  • 6.1 INTRODUCTION
  • 6.2 ANTI-AGING & WRINKLE REDUCTION
  • 6.3 SKIN REPAIR & REGENERATION
  • 6.4 MOISTURIZING & HYDRATION
  • 6.5 WHITENING & BRIGHTENING
  • 6.6 HAIR CARE
  • 6.7 ANTI-INFLAMMATORY & SOOTHING

7 PEPTIDE COSMETIC API MARKET, BY SOURCE

  • 7.1 INTRODUCTION
  • 7.2 PLANT-DERIVED PEPTIDES
  • 7.3 ANIMAL-DERIVED PEPTIDES
  • 7.4 BIOENGINEERED PEPTIDES
  • 7.5 CHEMICALLY SYNTHESIZED

8 PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY

  • 8.1 INTRODUCTION
  • 8.2 SKINCARE
  • 8.3 HAIRCARE
  • 8.4 INJECTABLE COSMETICS
  • 8.5 OTHERS

9 PEPTIDE COSMETIC API MARKET, BY REGION

  • 9.1 OVERVIEW
  • 9.2 NORTH AMERICA
    • 9.2.1 US
    • 9.2.2 CANADA
  • 9.3 EUROPE
    • 9.3.1 GERMANY
    • 9.3.2 UK
    • 9.3.3 FRANCE
    • 9.3.4 RUSSIA
    • 9.3.5 ITALY
    • 9.3.6 SPAIN
    • 9.3.7 REST OF EUROPE
  • 9.4 APAC
    • 9.4.1 CHINA
    • 9.4.2 INDIA
    • 9.4.3 JAPAN
    • 9.4.4 SOUTH KOREA
    • 9.4.5 MALAYSIA
    • 9.4.6 THAILAND
    • 9.4.7 INDONESIA
    • 9.4.8 REST OF APAC
  • 9.5 SOUTH AMERICA
    • 9.5.1 BRAZIL
    • 9.5.2 MEXICO
    • 9.5.3 ARGENTINA
    • 9.5.4 REST OF SOUTH AMERICA
  • 9.6 MEA
    • 9.6.1 GCC COUNTRIES
    • 9.6.2 SOUTH AFRICA
    • 9.6.3 REST OF MEA

10 COMPETITIVE LANDSCAPE

  • 10.1 INTRODUCTION
  • 10.2 MARKET SHARE ANALYSIS, 2023
  • 10.3 COMPETITOR DASHBOARD

11 COMPANY PROFILES

  • 11.1 DSM-FIRMENICH
    • 11.1.1 COMPANY OVERVIEW
    • 11.1.2 FINANCIAL OVERVIEW
    • 11.1.3 TYPES OFFERED
    • 11.1.4 PATENT DETAILS
    • 11.1.5 PRODUCTION CAPACITY
    • 11.1.6 SALES VOLUME
    • 11.1.7 PRICING ANALYSIS
    • 11.1.8 SWOT ANALYSIS
    • 11.1.9 KEY STRATEGY
  • 11.2 BACHEM
    • 11.2.1 COMPANY OVERVIEW
    • 11.2.2 FINANCIAL OVERVIEW
    • 11.2.3 TYPES OFFERED
    • 11.2.4 PATENT DETAILS
    • 11.2.5 PRODUCTION CAPACITY
    • 11.2.6 SALES VOLUME
    • 11.2.7 PRICING ANALYSIS
    • 11.2.8 SWOT ANALYSIS
    • 11.2.9 KEY STRATEGY
  • 11.3 LIPOTRUE SCIENCE
    • 11.3.1 COMPANY OVERVIEW
    • 11.3.2 TYPES OFFERED
    • 11.3.3 PATENT DETAILS
    • 11.3.4 PRODUCTION CAPACITY
    • 11.3.5 SALES VOLUME
    • 11.3.6 PRICING ANALYSIS
    • 11.3.7 SWOT ANALYSIS
    • 11.3.8 KEY STRATEGY
  • 11.4 CRODA
    • 11.4.1 COMPANY OVERVIEW
    • 11.4.2 FINANCIAL OVERVIEW
    • 11.4.3 TYPES OFFERED
    • 11.4.4 PATENT DETAILS
    • 11.4.5 PRODUCTION CAPACITY
    • 11.4.6 SALES VOLUME
    • 11.4.7 PRICING ANALYSIS
    • 11.4.8 SWOT ANALYSIS
    • 11.4.9 KEY STRATEGY
  • 11.5 CAREGEN
    • 11.5.1 COMPANY OVERVIEW
    • 11.5.2 TYPES OFFERED
    • 11.5.3 PATENT DETAILS
    • 11.5.4 PRODUCTION CAPACITY
    • 11.5.5 SALES VOLUME
    • 11.5.6 PRICING ANALYSIS
    • 11.5.7 SWOT ANALYSIS
    • 11.5.8 KEY STRATEGY
  • 11.6 BASF SE
    • 11.6.1 COMPANY OVERVIEW
    • 11.6.2 FINANCIAL OVERVIEW
    • 11.6.3 TYPES OFFERED
    • 11.6.4 PATENT DETAILS
    • 11.6.5 PRODUCTION CAPACITY
    • 11.6.6 SALES VOLUME
    • 11.6.7 PRICING ANALYSIS
    • 11.6.8 SWOT ANALYSIS
    • 11.6.9 KEY STRATEGY
  • 11.7 EVONIK INDUSTRIES AG
    • 11.7.1 COMPANY OVERVIEW
    • 11.7.2 FINANCIAL OVERVIEW
    • 11.7.3 TYPES OFFERED
    • 11.7.4 PATENT DETAILS
    • 11.7.5 PRODUCTION CAPACITY
    • 11.7.6 SALES VOLUME
    • 11.7.7 PRICING ANALYSIS
    • 11.7.8 SWOT ANALYSIS
    • 11.7.9 KEY STRATEGY
  • 11.8 GIVAUDAN ACTIVE BEAUTY
    • 11.8.1 COMPANY OVERVIEW
    • 11.8.2 FINANCIAL OVERVIEW
    • 11.8.3 TYPES OFFERED
    • 11.8.4 PATENT DETAILS
    • 11.8.5 PRODUCTION CAPACITY
    • 11.8.6 SALES VOLUME
    • 11.8.7 PRICING ANALYSIS
    • 11.8.8 SWOT ANALYSIS
    • 11.8.9 KEY STRATEGY
  • 11.9 ASHLAND GLOBAL HOLDINGS
    • 11.9.1 COMPANY OVERVIEW
    • 11.9.2 FINANCIAL OVERVIEW
    • 11.9.3 TYPES OFFERED
    • 11.9.4 PATENT DETAILS
    • 11.9.5 PRODUCTION CAPACITY
    • 11.9.6 SALES VOLUME
    • 11.9.7 PRICING ANALYSIS
    • 11.9.8 SWOT ANALYSIS
    • 11.9.9 KEY STRATEGY
  • 11.10 SYMRISE AG
    • 11.10.1 COMPANY OVERVIEW
    • 11.10.2 FINANCIAL OVERVIEW
    • 11.10.3 TYPES OFFERED
    • 11.10.4 PATENT DETAILS
    • 11.10.5 PRODUCTION CAPACITY
    • 11.10.6 SALES VOLUME
    • 11.10.7 PRICING ANALYSIS
    • 11.10.8 SWOT ANALYSIS
    • 11.10.9 KEY STRATEGY
  • 11.11 PROVITAL GROUP
    • 11.11.1 COMPANY OVERVIEW
    • 11.11.2 TYPES OFFERED
    • 11.11.3 PATENT DETAILS
    • 11.11.4 PRODUCTION CAPACITY
    • 11.11.5 SALES VOLUME
    • 11.11.6 PRICING ANALYSIS
    • 11.11.7 SWOT ANALYSIS
    • 11.11.8 KEY STRATEGY
  • 11.12 SPEC-CHEM INDUSTRY INC
    • 11.12.1 COMPANY OVERVIEW
    • 11.12.2 TYPES OFFERED
    • 11.12.3 PATENT DETAILS
    • 11.12.4 PRODUCTION CAPACITY
    • 11.12.5 SALES VOLUME
    • 11.12.6 PRICING ANALYSIS
    • 11.12.7 SWOT ANALYSIS
    • 11.12.8 KEY STRATEGY
  • 11.13 AMBIOPHARM
    • 11.13.1 COMPANY OVERVIEW
    • 11.13.2 TYPES OFFERED
    • 11.13.3 PATENT DETAILS
    • 11.13.4 PRODUCTION CAPACITY
    • 11.13.5 SALES VOLUME
    • 11.13.6 PRICING ANALYSIS
    • 11.13.7 SWOT ANALYSIS
    • 11.13.8 KEY STRATEGY
  • 11.14 LIPOTEC
    • 11.14.1 COMPANY OVERVIEW
    • 11.14.2 TYPES OFFERED
    • 11.14.3 PATENT DETAILS
    • 11.14.4 PRODUCTION CAPACITY
    • 11.14.5 SALES VOLUME
    • 11.14.6 PRICING ANALYSIS
    • 11.14.7 SWOT ANALYSIS
    • 11.14.8 KEY STRATEGY
  • 11.15 USV PRIVATE LIMITED
    • 11.15.1 COMPANY OVERVIEW
    • 11.15.2 TYPES OFFERED
    • 11.15.3 PATENT DETAILS
    • 11.15.4 PRODUCTION CAPACITY
    • 11.15.5 SALES VOLUME
    • 11.15.6 PRICING ANALYSIS
    • 11.15.7 SWOT ANALYSIS
    • 11.15.8 KEY STRATEGY
  • 11.16 CHEMISCHES LABORATORIUM DR. KURT RICHTER GMBH (CLR)
    • 11.16.1 COMPANY OVERVIEW
    • 11.16.2 TYPES OFFERED
    • 11.16.3 PATENT DETAILS
    • 11.16.4 PRODUCTION CAPACITY
    • 11.16.5 SALES VOLUME
    • 11.16.6 PRICING ANALYSIS
    • 11.16.7 SWOT ANALYSIS
    • 11.16.8 KEY STRATEGY
  • 11.17 ACTIVE PEPTIDE COMPANY
    • 11.17.1 COMPANY OVERVIEW
    • 11.17.2 TYPES OFFERED
    • 11.17.3 PATENT DETAILS
    • 11.17.4 PRODUCTION CAPACITY
    • 11.17.5 SALES VOLUME
    • 11.17.6 PRICING ANALYSIS
    • 11.17.7 SWOT ANALYSIS
    • 11.17.8 KEY STRATEGY
  • 11.18 SEIWA KASEI CO., LTD
    • 11.18.1 COMPANY OVERVIEW
    • 11.18.2 TYPES OFFERED
    • 11.18.3 PATENT DETAILS
    • 11.18.4 PRODUCTION CAPACITY
    • 11.18.5 SALES VOLUME
    • 11.18.6 PRICING ANALYSIS
    • 11.18.7 SWOT ANALYSIS
    • 11.18.8 KEY STRATEGY
  • 11.19 RS SYNTHESIS
    • 11.19.1 COMPANY OVERVIEW
    • 11.19.2 TYPES OFFERED
    • 11.19.3 PATENT DETAILS
    • 11.19.4 PRODUCTION CAPACITY
    • 11.19.5 SALES VOLUME
    • 11.19.6 PRICING ANALYSIS
    • 11.19.7 SWOT ANALYSIS
    • 11.19.8 KEY STRATEGY
  • 11.20 BCN PEPTIDES
    • 11.20.1 COMPANY OVERVIEW
    • 11.20.2 TYPES OFFERED
    • 11.20.3 PATENT DETAILS
    • 11.20.4 PRODUCTION CAPACITY
    • 11.20.5 SALES VOLUME
    • 11.20.6 PRICING ANALYSIS
    • 11.20.7 SWOT ANALYSIS
    • 11.20.8 KEY STRATEGY

LIST OF TABLES

  • TABLE 1 PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 2 PEPTIDE COSMETIC API MARKET, SOURCE, 2019-2035 (USD MILLION)
  • TABLE 3 PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION)
  • TABLE 4 PEPTIDE COSMETIC API MARKET, BY REGION, 2019-2035 (USD MILLION)
  • TABLE 5 PEPTIDE COSMETIC API MARKET, FOR NORTH AMERICA, BY COUNTRY, 2019-2035 (USD MILLION)
  • TABLE 6 PEPTIDE COSMETIC API MARKET, FOR NORTH AMERICA, BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 7 PEPTIDE COSMETIC API MARKET, FOR NORTH AMERICA, BY SOURCE, 2019-2035 (USD MILLION)
  • TABLE 8 PEPTIDE COSMETIC API MARKET, FOR NORTH AMERICA, BY END-USE INDUSTRY, 2019-2035 (USD MILLION)
  • TABLE 9 US: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 10 US: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION)
  • TABLE 11 US: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION)
  • TABLE 12 CANADA: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 13 CANADA: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION)
  • TABLE 14 CANADA: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION)
  • TABLE 15 PEPTIDE COSMETIC API MARKET, FOR EUROPE, BY COUNTRY, 2019-2035 (USD MILLION)
  • TABLE 16 PEPTIDE COSMETIC API MARKET, FOR EUROPE , BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 17 PEPTIDE COSMETIC API MARKET, FOR EUROPE, BY SOURCE, 2019-2035 (USD MILLION)
  • TABLE 18 PEPTIDE COSMETIC API MARKET, FOR EUROPE , BY END-USE INDUSTRY, 2019-2035 (USD MILLION)
  • TABLE 19 GERMANY: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 20 GERMANY: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION)
  • TABLE 21 GERMANY: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION)
  • TABLE 22 UK: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 23 UK: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION)
  • TABLE 24 UK: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION)
  • TABLE 25 FRANCE: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 26 FRANCE: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION)
  • TABLE 27 FRANCE: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION)
  • TABLE 28 RUSSIA: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 29 RUSSIA: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION)
  • TABLE 30 RUSSIA: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION)
  • TABLE 31 ITALY: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 32 ITALY: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION)
  • TABLE 33 ITALY: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION)
  • TABLE 34 SPAIN: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 35 SPAIN: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION)
  • TABLE 36 SPAIN: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION)
  • TABLE 37 REST OF EUROPE: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 38 REST OF EUROPE: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION)
  • TABLE 39 REST OF EUROPE: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION)
  • TABLE 40 PEPTIDE COSMETIC API MARKET, FOR APAC , BY COUNTRY, 2019-2035 (USD MILLION)
  • TABLE 41 PEPTIDE COSMETIC API MARKET, FOR APAC , BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 42 PEPTIDE COSMETIC API MARKET, FOR APAC , BY SOURCE, 2019-2035 (USD MILLION)
  • TABLE 43 PEPTIDE COSMETIC API MARKET, FOR APAC , BY END-USE INDUSTRY, 2019-2035 (USD MILLION)
  • TABLE 44 CHINA: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 45 CHINA: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION)
  • TABLE 46 CHINA: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION)
  • TABLE 47 INDIA: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 48 INDIA: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION)
  • TABLE 49 INDIA: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION)
  • TABLE 50 JAPAN: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 51 JAPAN: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION)
  • TABLE 52 JAPAN: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION)
  • TABLE 53 SOUTH KOREA: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 54 SOUTH KOREA: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION)
  • TABLE 55 SOUTH KOREA: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION)
  • TABLE 56 MALAYSIA: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 57 MALAYSIA: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION)
  • TABLE 58 MALAYSIA: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION)
  • TABLE 59 THAILAND: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 60 THAILAND: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION)
  • TABLE 61 THAILAND: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION)
  • TABLE 62 INDONESIA: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 63 INDONESIA: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION)
  • TABLE 64 INDONESIA: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION)
  • TABLE 65 REST OF APAC: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 66 REST OF APAC: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION)
  • TABLE 67 REST OF APAC: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION)
  • TABLE 68 PEPTIDE COSMETIC API MARKET, FOR SOUTH AMERICA , BY COUNTRY, 2019-2035 (USD MILLION)
  • TABLE 69 PEPTIDE COSMETIC API MARKET, FOR SOUTH AMERICA , BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 70 PEPTIDE COSMETIC API MARKET, FOR SOUTH AMERICA , BY SOURCE, 2019-2035 (USD MILLION)
  • TABLE 71 PEPTIDE COSMETIC API MARKET, FOR SOUTH AMERICA , BY END-USE INDUSTRY, 2019-2035 (USD MILLION)
  • TABLE 72 BRAZIL: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 73 BRAZIL: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION)
  • TABLE 74 BRAZIL: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION)
  • TABLE 75 MEXICO: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 76 MEXICO: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION)
  • TABLE 77 MEXICO: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION)
  • TABLE 78 ARGENTINA: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 79 ARGENTINA: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION)
  • TABLE 80 ARGENTINA: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION)
  • TABLE 81 REST OF SOUTH AMERICA: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 82 REST OF SOUTH AMERICA: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION)
  • TABLE 83 REST OF SOUTH AMERICA: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION)
  • TABLE 84 PEPTIDE COSMETIC API MARKET, FOR MEA, BY COUNTRY, 2019-2035 (USD MILLION)
  • TABLE 85 PEPTIDE COSMETIC API MARKET, FOR MEA, BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 86 PEPTIDE COSMETIC API MARKET, FOR MEA, BY SOURCE, 2019-2035 (USD MILLION)
  • TABLE 87 PEPTIDE COSMETIC API MARKET, FOR MEA, BY END-USE INDUSTRY, 2019-2035 (USD MILLION)
  • TABLE 88 GCC COUNTRIES: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 89 GCC COUNTRIES: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION)
  • TABLE 90 GCC COUNTRIES: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION)
  • TABLE 91 SOUTH AFRICA: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 92 SOUTH AFRICA: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION)
  • TABLE 93 SOUTH AFRICA: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION)
  • TABLE 94 REST OF MEA: PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2019-2035 (USD MILLION)
  • TABLE 95 REST OF MEA: PEPTIDE COSMETIC API MARKET, BY SOURCE, 2019-2035 (USD MILLION)
  • TABLE 96 REST OF MEA: PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2019-2035 (USD MILLION)
  • TABLE 97 DSM-FIRMENICH: PRODUCT OFFERED
  • TABLE 98 BACHEM: PRODUCT OFFERED
  • TABLE 99 LIPOTRUE SCIENCE: PRODUCT OFFERED
  • TABLE 100 CRODA: PRODUCT OFFERED
  • TABLE 101 CAREGEN: PRODUCT OFFERED
  • TABLE 102 BASF SE: PRODUCT OFFERED
  • TABLE 103 EVONIK INDUSTRIES AG: PRODUCT OFFERED
  • TABLE 104 GIVAUDAN ACTIVE BEAUTY: PRODUCT OFFERED
  • TABLE 105 ASHLAND GLOBAL HOLDINGS: PRODUCT OFFERED
  • TABLE 106 SYMRISE AG: PRODUCT OFFERED
  • TABLE 107 PROVITAL GROUP: PRODUCT OFFERED
  • TABLE 108 SPEC-CHEM INDUSTRY INC: PRODUCT OFFERED
  • TABLE 109 AMBIOPHARM: PRODUCT OFFERED
  • TABLE 110 LIPOTEC: PRODUCT OFFERED
  • TABLE 111 USV PRIVATE LIMITED: PRODUCT OFFERED
  • TABLE 112 CHEMISCHES LABORATORIUM DR. KURT RICHTER GMBH (CLR): PRODUCT OFFERED
  • TABLE 113 ACTIVE PEPTIDE COMPANY: PRODUCT OFFERED
  • TABLE 114 SEIWA KASEI CO., LTD: PRODUCT OFFERED
  • TABLE 115 RS SYNTHESIS: PRODUCT OFFERED
  • TABLE 116 BCN PEPTIDES: PRODUCT OFFERED

LIST OF FIGURES

  • FIGURE 1 PEPTIDE COSMETIC API MARKET: MARKET GROWTH FACTOR ANALYSIS (2019-2035)
  • FIGURE 3 SUPPLY CHAIN ANALYSIS: PEPTIDE COSMETIC API MARKET
  • FIGURE 5 PORTER'S FIVE FORCES MODEL: PEPTIDE COSMETIC API MARKET
  • FIGURE 6 PEPTIDE COSMETIC API MARKET, BY APPLICATION, 2023 (% SHARE)
  • FIGURE 7 PEPTIDE COSMETIC API MARKET, BY SOURCE, 2023 (% SHARE)
  • FIGURE 8 PEPTIDE COSMETIC API MARKET, BY END-USE INDUSTRY, 2023 (% SHARE)
  • FIGURE 9 GLOBAL PEPTIDE COSMETIC API MARKET PLAYERS: COMPETITIVE ANALSIS, 2023
  • FIGURE 10 INDUSTRY CONCENTRATION, 2024
  • FIGURE 11 COMPETITOR DASHBOARD: GLOBAL MILITARY DRIVER VISION ENHANCER
  • FIGURE 12 DSM-FIRMENICH: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 13 DSM-FIRMENICH: SWOT ANALYSIS
  • FIGURE 14 BACHEM: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 15 BACHEM: SWOT ANALYSIS
  • FIGURE 16 LIPOTRUE SCIENCE: SWOT ANALYSIS
  • FIGURE 17 CRODA: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 18 CRODA: SWOT ANALYSIS
  • FIGURE 19 CAREGEN: SWOT ANALYSIS
  • FIGURE 20 BASF SE: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 21 BASF SE: SWOT ANALYSIS
  • FIGURE 22 EVONIK: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 23 EVONIK INDUSTRIES AG: SWOT ANALYSIS
  • FIGURE 24 GIVAUDAN ACTIVE BEAUTY: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 25 GIVAUDAN ACTIVE BEAUTY: SWOT ANALYSIS
  • FIGURE 26 ASHLAND GLOBAL HOLDINGS: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 27 ASHLAND GLOBAL HOLDINGS: SWOT ANALYSIS
  • FIGURE 28 SYMRISE AG: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 29 SYMRISE AG: SWOT ANALYSIS
  • FIGURE 30 PROVITAL GROUP: SWOT ANALYSIS
  • FIGURE 31 SPEC-CHEM INDUSTRY INC: SWOT ANALYSIS
  • FIGURE 32 AMBIOPHARM: SWOT ANALYSIS
  • FIGURE 33 LIPOTEC: SWOT ANALYSIS
  • FIGURE 34 USV PRIVATE LIMITED: SWOT ANALYSIS
  • FIGURE 35 CHEMISCHES LABORATORIUM DR. KURT RICHTER GMBH (CLR): SWOT ANALYSIS
  • FIGURE 36 ACTIVE PEPTIDE COMPANY: SWOT ANALYSIS
  • FIGURE 37 SEIWA KASEI CO., LTD: SWOT ANALYSIS
  • FIGURE 38 RS SYNTHESIS: SWOT ANALYSIS
  • FIGURE 39 BCN PEPTIDES: SWOT ANALYSIS